| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $786.6M | +7.9% |
| Cost of Revenue | $294.6M | -4.8% |
| Gross Profit | $491.9M | +17.3% |
| R&D Expense | $125.4M | +4.2% |
| SG&A Expense | $96.2M | +2.5% |
| Operating Income | -$89.3M | +26.7% |
| Pre-tax Income | -$80.9M | +21.9% |
| Income Tax | $4.3M | +19.1% |
| Net Income | -$85.3M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $190.6M | -37.6% |
| Short-term Investments | $163.8M | -4.4% |
| Accounts Receivable | $88.2M | -4.7% |
| Current Assets | $506.3M | -19.9% |
| Total Assets | $605.6M | -18.3% |
| Current Liabilities | $397.5M | +4.6% |
| Total Liabilities | $408.2M | +6.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $53.0M | +2745.5% |
| Capital Expenditures | $2.3M | +263.9% |
| Investing Cash Flow | $1.1M | +104.3% |
| Financing Cash Flow | -$171.7M | -994.8% |
| Free Cash Flow | $50.7M | +2024.3% |
| +20.5% |
| EPS (Basic) | -$0.56 | +21.1% |
| EPS (Diluted) | -$0.56 | +21.1% |
| Stockholders' Equity |
| $197.4M |
| -44.7% |